Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 2

In campaign 1, 75.3 kg of (S)-2-(methylamino)-1-[5-(trifluoromethyl)-2-pyrazinylamino]propane hydrochloride salt was prepared in two stages from (S)-2-(N-benzyl-N-methylamino)-1-propanamine d-tartaric acid salt. The first stage was the alkylation of 2-chloro-5-(trifluoromethyl)pyrazine. The second stage was the removal of the benzyl protecting group by hydrogenolysis. In campaign 2, 251 kg of (S)-2-(methylamino)-1-[5-(trifluoromethyl)-2-pyrazinylamino]propane hydrochloride salt was produced, this time starting from the d-mandelic acid salt of (S)-2-(N-benzyl-N-methylamino)-1-propanamine. Investigations into alternative routes of synthesis for (S)-2-(methylamino)-1-[5-(trifluoromethyl)-2-pyrazinylamino]propane identified two options: one via (5R)-5-methyl-3-[5-(trifluoromethyl)pyrazin-2-yl]-1,2λ6,3-oxathiazolidin-2,2-dione and the other via (S)-2-(N-benzyloxycarbonyl-N-methylamino)propionitrile.

Authors

Institutions

Publication Details

Journal
Organic Process Research & Development
Published
2026-11-18
DOI
https://doi.org/10.1021/acs.oprd.6c00297
Citations
3
Primary Topic
Chemical Synthesis and Analysis
Type
article
Field-Weighted Citation Impact
3.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 2

Paul Leong, John S Carey, Andrew Knowles, Harrison Holmes
3 citations
Organic Process Research & Development
Chemical Synthesis and Analysis
3.78
article

Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 2

Paul Leong, John S Carey, Andrew Knowles, Harrison Holmes
article en
3 citations

Abstract

In campaign 1, 75.3 kg of (S)-2-(methylamino)-1-[5-(trifluoromethyl)-2-pyrazinylamino]propane hydrochloride salt was prepared in two stages from (S)-2-(N-benzyl-N-methylamino)-1-propanamine d-tartaric acid salt. The first stage was the alkylation of 2-chloro-5-(trifluoromethyl)pyrazine. The second stage was the removal of the benzyl protecting group by hydrogenolysis. In campaign 2, 251 kg of (S)-2-(methylamino)-1-[5-(trifluoromethyl)-2-pyrazinylamino]propane hydrochloride salt was produced, this time starting from the d-mandelic acid salt of (S)-2-(N-benzyl-N-methylamino)-1-propanamine. Investigations into alternative routes of synthesis for (S)-2-(methylamino)-1-[5-(trifluoromethyl)-2-pyrazinylamino]propane identified two options: one via (5R)-5-methyl-3-[5-(trifluoromethyl)pyrazin-2-yl]-1,2λ6,3-oxathiazolidin-2,2-dione and the other via (S)-2-(N-benzyloxycarbonyl-N-methylamino)propionitrile.

Organic Process Research & Development
The Priory Hospital (GB), Lonza (Switzerland) (CH)
Openalex Percentile: Top 9%
Chemical Synthesis and Analysis
3.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon